Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors.
Yinghan SuJiang LiWeidan JiGang WangLin FangQin ZhangLin AngMin ZhaoYuan SenLei ChenJunnian ZhengChangqing SuLunxiu QinPublished in: Journal for immunotherapy of cancer (2022)
The chimeric OncoViron is a novel broad-spectrum anticancer product with multiple mechanisms of synergistic and potentiated immunotherapy, creating a good opportunity for combined immunotherapy against solid tumors.